Document ID: chunk:federal_register_of_legislation:C2025C00090:section:100a
Version: federal_register_of_legislation:C2025C00090
Segment Type: section
Provision Reference: s 100A
Character Range: 507492–508672

100A  Establishment and membership of the Pharmaceutical Benefits Advisory Committee
 (1) There is to be a Committee called the Pharmaceutical Benefits Advisory Committee.
 (2) The Committee is to consist of the Chairperson and at least 11, but not more than 20, other members.
Note: One of the members of the Committee (other than the Chairperson) may be appointed as the Deputy Chairperson of the Committee: see subsection 100B(1D).
 (3) Members forming at least 2/3 of the total membership of the Committee are to be selected from the following:
 (aa) industry;
 (a) consumers;
 (b) health economists;
 (c) practising community pharmacists;
 (d) general practitioners;
 (e) clinical pharmacologists;
 (f) specialists;
with at least one member selected from each of the interests or professions mentioned in paragraphs (a) to (f).
 (4) The remaining members (if any) of the Committee are to be persons whom the Minister is satisfied have qualifications or experience:
 (a) in a field relevant to the functions of the Committee; and
 (b) that would enable them to contribute meaningfully to the deliberations of the Committee.
 (5) The Chairperson is a member of the Committee.